` SENS (Senseonics Holdings Inc) vs S&P 500 Comparison - Alpha Spread

S
SENS
vs
S&P 500

Over the past 12 months, SENS has outperformed S&P 500, delivering a return of +19% compared to the S&P 500's +13% growth.

Stocks Performance
SENS vs S&P 500

Loading
SENS
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
SENS vs S&P 500

Loading
SENS
S&P 500
Difference
www.alphaspread.com

Performance By Year
SENS vs S&P 500

Loading
SENS
S&P 500
Add Stock

Competitors Performance
Senseonics Holdings Inc vs Peers

Senseonics Holdings Inc
Glance View

Market Cap
460.4m USD
Industry
Health Care

Senseonics Holdings, Inc. engages in the design, development, and commercialization of an implantable continuous glucose monitoring system for people with diabetes. The company is headquartered in Germantown, Maryland and currently employs 121 full-time employees. The company went IPO on 2015-03-04. The firm is focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community. Its Eversense, Eversense XL, and Eversense E3 continuous glucose monitoring (CGM) systems are designed to continually measure glucose levels in people with diabetes via an under-the-skin sensor, a removable and rechargeable smart transmitter, and a mobile application for real-time diabetes monitoring and management for a period of up to six months. The company is also developing its Gemini product variation to allow for a two-in-one glucose monitoring system combining the functionality of CGM and Flash Glucose Monitoring (FGM), in an implantable sensor that may be utilized with a smart transmitter to get continuous glucose readings and alerts or be utilized through a swipe over the sensor with a smart phone to get on-demand glucose readings without a smart transmitter.

SENS Intrinsic Value
0.13 USD
Overvaluation 78%
Intrinsic Value
Price
S
Back to Top